27 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
technology and, as such, are not separately classified.
Product candidates in later stages of clinical development generally have higher development … following the balance sheet date are classified as current portion of deferred revenue in the consolidated balance sheets. Amounts not expected
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
programs and our platform technology and, as such, are not separately classified.
Product candidates in later stages of clinical development generally … within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the consolidated balance sheets. Amounts
10-K
ur64 b1sti
18 Mar 21
Annual report
6:31am
424B4
4ey1dl yl
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
na149o744 t3p5
1 Feb 21
Draft registration statement
12:00am
10-Q
w0v24 8s9hksf
10 Dec 20
Quarterly report
4:46pm
8-K
do3fh0ca8 82j1x1
4 Nov 20
Amendments to Articles of Incorporation or Bylaws
5:00pm
S-8
EX-99.3
6xodj
30 Oct 20
Registration of securities for employees
5:12pm
424B4
dhy50se6p44oiq9rs1
30 Oct 20
Prospectus supplement with pricing info
4:54pm